Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.

Bouganim N, Dranitsaris G, Hopkins S, Vandermeer L, Godbout L, Dent S, Wheatley-Price P, Milano C, Clemons M.

Curr Oncol. 2012 Dec;19(6):e414-21. doi: 10.3747/co.19.1074.

PMID:
23300365
[PubMed]
Free PMC Article
2.

Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting.

Dranitsaris G, Bouganim N, Milano C, Vandermeer L, Dent S, Wheatley-Price P, Laporte J, Oxborough KA, Clemons M.

J Support Oncol. 2013 Mar;11(1):14-21.

PMID:
22763232
[PubMed - indexed for MEDLINE]
3.

Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.

Shih V, Wan HS, Chan A.

Ann Pharmacother. 2009 Mar;43(3):444-52. doi: 10.1345/aph.1L437. Epub 2009 Feb 3.

PMID:
19193584
[PubMed - indexed for MEDLINE]
4.

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.

Schwartzberg L, Morrow G, Balu S, Craver C, Gayle J, Cox D.

Curr Med Res Opin. 2011 Aug;27(8):1613-22. doi: 10.1185/03007995.2011.596201. Epub 2011 Jun 22.

PMID:
21696263
[PubMed - indexed for MEDLINE]
5.

Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.

Liau CT, Chu NM, Liu HE, Deuson R, Lien J, Chen JS.

Support Care Cancer. 2005 May;13(5):277-86. Epub 2005 Mar 16.

PMID:
15770489
[PubMed - indexed for MEDLINE]
6.
7.

Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.

Navari RM.

J Support Oncol. 2003 Jul-Aug;1(2):89-103. Review.

PMID:
15352652
[PubMed - indexed for MEDLINE]
8.

Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.

Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, Burke TA, Gu A, Roila F.

J Pain Symptom Manage. 2014 May;47(5):839-848.e4. doi: 10.1016/j.jpainsymman.2013.06.012. Epub 2013 Sep 24.

PMID:
24075401
[PubMed - in process]
9.

Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists.

Majem M, Moreno ME, Calvo N, Feliu A, Pérez J, Mangues MA, Barnadas A.

Support Care Cancer. 2011 Dec;19(12):1983-90. doi: 10.1007/s00520-010-1042-3. Epub 2010 Nov 18.

PMID:
21086141
[PubMed - indexed for MEDLINE]
10.

Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.

Grunberg SM, Deuson RR, Mavros P, Geling O, Hansen M, Cruciani G, Daniele B, De Pouvourville G, Rubenstein EB, Daugaard G.

Cancer. 2004 May 15;100(10):2261-8.

PMID:
15139073
[PubMed - indexed for MEDLINE]
Free Article
11.

Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.

Abbrederis K, Lorenzen S, Rothling N, Ihbe-Heffinger A, Schuster T, Peschel C, Lordick F.

Onkologie. 2009 Feb;32(1-2):30-4. doi: 10.1159/000183735. Epub 2009 Jan 20.

PMID:
19209016
[PubMed - indexed for MEDLINE]
12.

The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.

Ihbe-Heffinger A, Ehlken B, Bernard R, Berger K, Peschel C, Eichler HG, Deuson R, Thödtmann J, Lordick F.

Ann Oncol. 2004 Mar;15(3):526-36.

PMID:
14998860
[PubMed - indexed for MEDLINE]
Free Article
13.

Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings.

Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H.

Support Care Cancer. 2007 May;15(5):497-503. Epub 2006 Nov 14.

PMID:
17103197
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of palonosetron as salvage treatment in the prevention of chemotherapy-induced nausea and vomiting in patients receiving low emetogenic chemotherapy (LEC).

Hesketh PJ, Morrow G, Komorowski AW, Ahmed R, Cox D.

Support Care Cancer. 2012 Oct;20(10):2633-7. doi: 10.1007/s00520-012-1527-3. Epub 2012 Jun 24.

PMID:
22733373
[PubMed - indexed for MEDLINE]
15.

Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.

Balu S, Buchner D, Craver C, Gayle J.

Clin Ther. 2011 Apr;33(4):443-55. doi: 10.1016/j.clinthera.2011.04.009.

PMID:
21635990
[PubMed - indexed for MEDLINE]
16.

Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy.

Feinberg B, Gilmore J, Haislip S, Jackson J, Jain G, Balu S, Buchner D.

Support Care Cancer. 2012 Mar;20(3):615-23. doi: 10.1007/s00520-011-1140-x. Epub 2011 Mar 29.

PMID:
21761096
[PubMed - indexed for MEDLINE]
17.

Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting.

Dando TM, Perry CM.

Drugs. 2004;64(7):777-94. Review.

PMID:
15025555
[PubMed - indexed for MEDLINE]
18.

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).

Aapro M, Molassiotis A, Dicato M, Peláez I, Rodríguez-Lescure Á, Pastorelli D, Ma L, Burke T, Gu A, Gascon P, Roila F; PEER investigators.

Ann Oncol. 2012 Aug;23(8):1986-92. Epub 2012 Mar 6.

PMID:
22396444
[PubMed - indexed for MEDLINE]
Free Article
19.

Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.

López-Jiménez J, Martín-Ballesteros E, Sureda A, Uralburu C, Lorenzo I, del Campo R, Fernández C, Calbacho M, García-Belmonte D, Fernández G.

Haematologica. 2006 Jan;91(1):84-91.

PMID:
16434375
[PubMed - indexed for MEDLINE]
Free Article
20.

Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment.

Rodgers C, Kollar D, Taylor O, Bryant R, Crockett K, Gregurich MA, Hockenberry M.

Cancer Nurs. 2012 May-Jun;35(3):203-10. doi: 10.1097/NCC.0b013e3182281493.

PMID:
21915041
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk